Fantl et al., 1953 - Google Patents
The interaction of thrombin with the plasma components of man and experimental animals.Fantl et al., 1953
- Document ID
- 8455728096089561626
- Author
- Fantl P
- Ebbels L
- Publication year
- Publication venue
- Australian Journal of Experimental Biology & Medical Science
External Links
Snippet
The plasma of many patients suffering from obstructive jaundice and multiple myelomata shows a delayed thrombin clotting time. The plasmas of the rat, guinea-pig and rabbit also show a delayed thrombin clotting time when compared to human material. The difference in …
- 210000002381 Plasma 0 title abstract description 130
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nilsson et al. | Determination of fibrinogen and fibrinogenolytic activity | |
| Blauhut et al. | Substitution therapy with an antithrombin III concentrate in shock and DIC | |
| Bauer et al. | Antithrombin" Chicago": a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia | |
| EP0244834A2 (en) | Process for producing a factor V concentrate | |
| Tijburg et al. | Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. The role of flow and factor IX/IXa | |
| Pitney et al. | Blood fibrinolytic activity during Arvin therapy | |
| Kelly et al. | Antihemophilic factor inhibitors: Management with prothrombin complex concentrates | |
| Vinazzer | Clinical use of antithrombin III concentrates | |
| US4287180A (en) | Method for treating blood clotting factor inhibitors | |
| Henderson et al. | The thrombotic activity of activation product | |
| Thompson et al. | Removal of heparin and protamine from plasma | |
| Gitel et al. | The antithrombotic effects of warfarin and heparin following infusions of tissue thromboplastin in rabbits: clinical implications | |
| Surgenor et al. | A system for the separation of the protein components of human plasma. II. The components of the clotting process. | |
| JPH0424360B2 (en) | ||
| Prandoni et al. | The Anti-Coagulants: Heparin and the Dicoumarin-3, 3'Methylene-Bis-(4-Hydroxycoumarin) | |
| Nilsson et al. | Erosive hemorrhagic gastroduodenitis with fibrinolysis and low factor XIII. | |
| LANE et al. | Factor V antibody and disseminated intravascular coagulation | |
| Fantl et al. | The interaction of thrombin with the plasma components of man and experimental animals. | |
| Feldman et al. | Haemostatic abnormalities in canine Cushing's syndrome | |
| Macfarlane | The action of soya-bean trypsin inhibitor as an anti-thromboplastin in blood coagulation | |
| Sandberg et al. | Studies of inhibition of the plasmin-plasminogen fibrinolytic enzyme system in patients with myocardial infarction∗ | |
| Jeljaszewicz et al. | Intravascular Coagulation and Fibrinolysis by Stapliylocoagiilase. Comparison with Thrombin | |
| Crisnic et al. | Disseminated intravascular coagulation and acute renal failure | |
| Kierulf et al. | Fibrinaemia and Multiple Thrombi in Pancreatic Carcinoma: A Case Studied with Quantitative N‐Terminal Analysis | |
| Sorenson et al. | A Synthetic Anticoagulant: A Polysulfuric Acid Ester of Polyanhydromannuronic Acid (Paritol) Experience with Its Use in Man |